Financials

News Discussions Technicals Forecast Seasonals

EBIT of GENMAB AS

Annual data

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

TTM

‪0.00‬

‪‪250.00 M‬‬

‪‪500.00 M‬‬

‪‪750.00 M‬‬

‪‪1.00 B‬‬

Period

Value

Change

Change %

TTM

‪‪926.08 M‬‬

‪‪−10.16 M‬‬

‪−1.09‬%

2024

‪‪936.24 M‬‬

+‪‪222.64 M‬‬

+‪31.20‬%

2023

‪‪713.60 M‬‬

‪‪−131.78 M‬‬

‪−15.59‬%

2022

‪‪845.38 M‬‬

+‪‪439.57 M‬‬

+‪108.32‬%

2021

‪‪405.81 M‬‬

‪‪−445.27 M‬‬

‪−52.32‬%

2020

‪‪851.08 M‬‬

+‪‪498.05 M‬‬

+‪141.08‬%

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

Quarterly data

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪0.00‬

‪‪80.00 M‬‬

‪‪160.00 M‬‬

‪‪240.00 M‬‬

‪‪320.00 M‬‬

Period

Value

Change

Change %

Q4 '24

‪‪292.92 M‬‬

+‪‪8.90 M‬‬

+‪3.13‬%

Q3 '24

‪‪284.01 M‬‬

+‪‪41.06 M‬‬

+‪16.90‬%

Q2 '24

‪‪242.95 M‬‬

+‪‪135.83 M‬‬

+‪126.80‬%

Q1 '24

‪‪107.12 M‬‬

‪‪−116.84 M‬‬

‪−52.17‬%

Q4 '23

‪‪223.96 M‬‬

‪‪−5.71 M‬‬

‪−2.49‬%

Q3 '23

‪‪229.67 M‬‬

+‪‪29.16 M‬‬

+‪14.54‬%

Q2 '23

‪‪200.52 M‬‬

+‪‪141.97 M‬‬

+‪242.50‬%

Q1 '23

‪‪58.55 M‬‬

‪‪−298.78 M‬‬

‪−83.62‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19

Q1 '19

Q4 '18

Q3 '18

Q2 '18

Q1 '18

Q4 '17

Q3 '17

Q2 '17